Register for patients with chronic pain considering neuromodulatory therapies
Nationwide Dynamic Register for Screening, Evaluation and Follow-up of Patients Suffering From Chronic Pain Syndromes and Treated by Means of Invasive Neuromodulation.
This study is creating a registry for patients in Belgium with chronic pain to track their experiences as they explore new treatment options like spinal cord stimulation.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 7000 (estimated) |
| Sex | All |
| Sponsor | University Hospital, Antwerp Academic / other |
| Locations | 1 site (Edegem, Antwerp) |
| Trial ID | NCT06835868 on ClinicalTrials.gov |
What this trial studies
This study involves creating a dynamic register for patients in Belgium suffering from chronic pain syndromes, specifically persistent spinal pain syndromes and complex regional pain syndromes. Patients will be monitored as they undergo a multidisciplinary evaluation and consider treatment options involving invasive neuromodulation techniques, such as spinal cord stimulation. The register will track the screening process, trial therapy, and long-term follow-up to assess outcomes and improve patient care.
Who should consider this trial
Good fit: Ideal candidates are patients living in Belgium with chronic pain syndromes who are being considered for invasive neuromodulatory therapies.
Not a fit: Patients with acute pain syndromes will not benefit from this study.
Why it matters
Potential benefit: If successful, this could enhance treatment options and improve quality of life for patients with chronic pain.
How similar studies have performed: Other studies have shown success with similar approaches in managing chronic pain through neuromodulation techniques.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * chronic pain syndromes Exclusion Criteria: * acute pain syndromes
Where this trial is running
Edegem, Antwerp
- UZA, multidisciplinary pain center — Edegem, Antwerp, Belgium (Recruiting)
Study contacts
- Study coordinator: Guy H HANS, MD, PhD
- Email: guy.hans@uza.be
- Phone: 003238213000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.